No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.
暂无分享,去创建一个
Cornelis J H van de Velde | Marta Fiocco | I. Nagtegaal | C. Marijnen | C. V. D. van de Velde | H. Rutten | I. Jürgenliemk-Schulz | R. Nout | M. Fiocco | Ina M Jürgenliemk-Schulz | Iris D Nagtegaal | Lisette M Wiltink | Remi A Nout | Elma Meershoek-Klein Kranenbarg | Jan J Jobsen | Harm J T Rutten | Carien L Creutzberg | Corrie A M Marijnen | C. Creutzberg | J. Jobsen | E. Meershoek-Klein Kranenbarg | L. Wiltink | C. J. van de Velde
[1] Lars Påhlman,et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Hein Putter,et al. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models , 2010, Comput. Methods Programs Biomed..
[3] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[4] T. Whelan,et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.
[5] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[6] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[7] K. Nouta,et al. Revision surgery is overestimated in hip replacement , 2012, Bone & joint research.
[8] M Schemper,et al. A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.
[9] Stephanie Lamart,et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. , 2011, The Lancet. Oncology.
[10] W. Hohenberger,et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Hein Putter,et al. mstate: An R Package for the Analysis of Competing Risks and Multi-State Models , 2011 .
[12] J. Ruterbusch,et al. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy. , 2009, Gynecologic oncology.
[13] C. V. D. van de Velde,et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Randall W Burt,et al. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. , 2010, International journal of radiation oncology, biology, physics.
[15] M. Casparie,et al. Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[16] P. Koper,et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. , 2001, International journal of radiation oncology, biology, physics.
[17] J. Coebergh,et al. Prevalence of multiple malignancies in the Netherlands in 2007 , 2011, International journal of cancer.
[18] A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer , 2007, American journal of clinical oncology.
[19] Hein Putter,et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[21] Rieken,et al. [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[22] C. Tropé,et al. Long-term outcomes after pelvic radiation for early-stage endometrial cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Andrea Ng,et al. Second malignant neoplasms: assessment and strategies for risk reduction. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[25] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .